利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.045 秒)

    Fully human hybridoma fusion partner cell lines
    3.
    发明申请
    Fully human hybridoma fusion partner cell lines 有权
    全人类杂交瘤融合伴侣细胞系

    公开(公告)号：US20070141064A1

    公开(公告)日：2007-06-21

    申请号：US11510490

    申请日：2006-08-25

    申请人： Ilya Trakht ,  Gavreel Kalantarov

    发明人： Ilya Trakht ,  Gavreel Kalantarov

    IPC分类号： A61K39/395 ,  C07H21/04 ,  C12P21/06 ,  C12N5/06 ,  C07K14/82 ,  C07K16/30

    CPC分类号： C12N5/163 ,  C07K16/00 ,  C07K2317/21

    摘要： Certain aspects of the present invention are directed to new fully human fusion partner cell lines called human Karyochi cells, and to methods for making them. Human Karyochi cells are then fused with human antibody-secreting lymphoid cells to make fully human hybridomas called Karyochi-based hybridomas, which likewise secrete fully human monoclonal antibodies. Human Karyochi cells are made by isolating a donor nucleus that is substantially free of cytoplasm from either a first malignant B-lymphocyte cell line or a normal B-lymphocyte, and transferring the donor nucleus into the cytoplasm of a recipient cell from a second T- or B-lymphoid cell line. With time the nuclei synchronize and fuse to form the chimeric Karyochi fusion partner cell line. Nuclear transfer can be accomplished using intra-cytosolic nucleus injection or by impact-induced nucleus administration.

    摘要翻译： 本发明的某些方面涉及称为人类Karyochi细胞的新的完全人融合伙伴细胞系，以及制备它们的方法。 然后将人类Karyochi细胞与人抗体分泌淋巴样细胞融合以制备完全人类杂交瘤，称为基于核型的杂交瘤，其同样分泌完全的人单克隆抗体。 通过从第一恶性B淋巴细胞细胞系或正常B淋巴细胞中分离基本上不含细胞质的供体核，并将供体核从第二T细胞转移到受体细胞的细胞质中制备人类核型细胞， 或B淋巴细胞系。 随着时间的推移，核同步并融合形成嵌合的Karyochi融合伙伴细胞系。 核转移可以使用胞内核注射或通过冲击诱导的核给药来完成。

    Fully human hybridoma fusion partner cell lines
    4.
    发明授权
    Fully human hybridoma fusion partner cell lines 有权
    全人类杂交瘤融合伴侣细胞系

    公开(公告)号：US08859278B2

    公开(公告)日：2014-10-14

    申请号：US11510490

    申请日：2006-08-25

    申请人： Ilya Trakht ,  Gavreel Kalantarov

    发明人： Ilya Trakht ,  Gavreel Kalantarov

    IPC分类号： C12N5/0781 ,  C12N5/09 ,  C12N5/10 ,  C07K16/00 ,  C12N5/16

    CPC分类号： C12N5/163 ,  C07K16/00 ,  C07K2317/21

    摘要： Certain aspects of the present invention are directed to new fully human fusion partner cell lines called human Karyochi cells, and to methods for making them. Human Karyochi cells are then fused with human antibody-secreting lymphoid cells to make fully human hybridomas called Karyochi-based hybridomas, which likewise secrete fully human monoclonal antibodies. Human Karyochi cells are made by isolating a donor nucleus that is substantially free of cytoplasm from either a first malignant B-lymphocyte cell line or a normal B-lymphocyte, and transferring the donor nucleus into the cytoplasm of a recipient cell from a second T- or B-lymphoid cell line. With time the nuclei synchronize and fuse to form the chimeric Karyochi fusion partner cell line. Nuclear transfer can be accomplished using intra-cytosolic nucleus injection or by impact-induced nucleus administration.

    摘要翻译： 本发明的某些方面涉及称为人类Karyochi细胞的新的完全人融合伙伴细胞系，以及制备它们的方法。 然后将人类Karyochi细胞与人抗体分泌淋巴样细胞融合以制备完全人类杂交瘤，称为基于核型的杂交瘤，其同样分泌完全的人单克隆抗体。 通过从第一恶性B淋巴细胞细胞系或正常B淋巴细胞中分离基本上不含细胞质的供体核，并将供体核从第二T细胞转移到受体细胞的细胞质中制备人类核型细胞， 或B淋巴细胞系。 随着时间的推移，核同步并融合形成嵌合的Karyochi融合伙伴细胞系。 核转移可以使用胞内核注射或通过冲击诱导的核给药来完成。

    FROZEN CELL AND TISSUE MICROARRAYS
    5.
    发明申请
    FROZEN CELL AND TISSUE MICROARRAYS 审中-公开
    冷冻细胞和组织微量元素

    公开(公告)号：US20100323907A1

    公开(公告)日：2010-12-23

    申请号：US12446575

    申请日：2006-10-27

    申请人： Long Ai Ton-That ,  Gavreel Kalantarov ,  Ilya Trakht

    发明人： Long Ai Ton-That ,  Gavreel Kalantarov ,  Ilya Trakht

    IPC分类号： C40B30/04 ,  C12N5/071 ,  G01N33/53 ,  C12Q1/68 ,  C40B50/06 ,  C40B40/02

    CPC分类号： A01N1/0231 ,  A01N1/0221

    摘要： The invention is directed to a new composition for making a housing block for cryosectioning comprising agarose and optimal cutting temperature medium. The invention is further directed to new methods for making a frozen section microarray of fresh non-fixed frozen cell or tissue samples that undergo only one freeze-thaw cycle before being used in a biological assay.

    摘要翻译： 本发明涉及用于制备用于冷冻切片的壳体块的新组合物，其包括琼脂糖和最佳切割温度培养基。 本发明进一步涉及用于制造新鲜未固定的冷冻细胞或组织样品的冷冻切片微阵列的新方法，其仅在生物测定中使用之前仅经历一个冻融循环。